Latest Industry Insights

Technology Networks spoke with Nicola Alderson, COO at Anthony Nolan, to discuss some of the current stem cell supply challenges and learn more about how donor registries can help overcome stem cell supply chain issues.

This article will detail the quantitative and qualitative benefits of adopting digital twin technology throughout the different steps of battery production.

In this interview, Xiaobo Wang discusses some of the NovoCyte Opteon’s advanced spectral capabilities and how they help to address existing challenges in flow cytometry.

Technology Networks visited eXmoor Pharma to learn more about its journey to becoming a licensed cell and gene therapy CDMO. The guided tour highlighted the facility as a flexible and scalable manufacturing hub.

Jeffery Zonderman, senior vice-president at Bruker Applied MS, joined Technology Networks for an interview at this year's American Society for Mass Spectrometry event.

Learn from James Hallam, vice president of the Research, Development and Advanced Testing Business segment at Waters Corporation, about how technological advancements in mass spectrometry are powering new discoveries in omics research.

In bioanalysis, AI could alleviate preclinical and clinical bioanalytical data processing and analysis. Here, Mary Belfast from Teva Branded Pharmaceuticals, discusses some of the latest guidelines on AI implementation and validation in bioanalysis.

Dr. Sergio Pérez Rosal explains why, in his opinion, “hope is not lost” and the therapeutic potential of psychedelics for the treatment of psychiatric disorders could still be unlocked. But what happens next must be firmly rooted in science.

Technology Networks joined Tarun Anumol for a discussion about the major challenges facing PFAS testing at this year’s ASMS conference.

Technology Networks joined Agilent Technologies for a discussion about new advances in gas chromatography at this year’s ASMS conference.